Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsUpgradesPrice Target
Barclays analyst Glen Santangelo upgrades Alvotech (NASDAQ:ALVO) from Underweight to Overweight and raises the price target from $4 to $8.
Barclays analyst Glen Santangelo upgrades Alvotech (NASDAQ:ALVO) from Underweight to Overweight and raises the price target from $4 to $8.